Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment
Article first published online: 16 DEC 2013
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Special Issue: Guest Editors – Ayşegül Özerdem and Natalie Rasgon
Volume 16, Issue 1, pages 72–82, February 2014
How to Cite
Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment. Bipolar Disord 2014: 16: 72–82. © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd., , , , .
- Issue published online: 28 JAN 2014
- Article first published online: 16 DEC 2013
- Manuscript Accepted: 20 JUL 2013
- Manuscript Received: 2 AUG 2012
- bipolar disorder;
- gender difference;
- thyroid function
Previous studies have provided evidence of subtle thyroid hormone metabolism abnormalities in patients with mood disorders. Although these studies are informative, the precise role of the hypothalamic-pituitary-thyroid axis in bipolar disorder, especially in women, remains unclear. We sought to further corroborate thyroid function in patients with bipolar disorder in comparison to patients with other psychiatric, as well as non-psychiatric, diagnoses.
In this retrospective, cross-sectional, naturalistic study, serum thyroid-stimulating hormone (TSH) levels in a total sample of 3,204 patients were compared. The study sample included patients with bipolar disorder (n = 469), unipolar depression (n = 615), and other psychiatric diagnoses (n = 999), patients from endocrinology clinics (n = 645), and patients from dermatology clinics (n = 476). Analyses were completed using two different normal ranges for TDH: a high normal range (0.4–5.0 μIU/mL) and a low normal range (0.3–3.0 μIU/mL).
Patients with bipolar disorder showed significantly higher serum TSH levels compared to all other groups. In women, the rate of above normal range TSH was highest in patients with bipolar disorder for both high (5.0 μIU/mL; 12.1%) and low (3.0 μIU/mL; 30.4%) upper normal limits. In patients with bipolar disorder, serum TSH levels did not differ significantly between different mood states. In the lithium-treated patients (n = 240), a significantly lower percentage of women (55.9%) compared to men (71.2%) fell within the 0.3–3.0 μIU/mL normal TSH window (p = 0.016). For the high normal range (0.4–5.0 μIU/mL), serum lithium levels above 0.8 mmol/L were associated with a significantly lower proportion of female patients (59.2%) falling within the normal range than male patients (88.9%). Non-lithium treatment was not associated with a gender difference.
Our findings show a higher rate of TSH abnormality in patients with bipolar disorder, particularly those taking lithium, compared to those with other psychiatric and medical conditions. Lithium-associated thyroid dysregulation occurs more frequently in female patients. Using the low normal range TSH values at follow-up can increase sensitivity in recognizing hyperthyroidism in lithium-treated female patients, and help in preventing the development of subclinical hypothyroidism and an adverse course of illness.